Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reduced Itch Associated With Dupilumab Treatment In 4 Patients With Prurigo Nodularis.

Literature DB >> 30427989

Reduced Itch Associated With Dupilumab Treatment In 4 Patients With Prurigo Nodularis.

Nicholas K Mollanazar¹, May Elgash¹, Leslie Weaver¹, Rodrigo Valdes-Rodriguez¹, Sylvia Hsu¹.

Abstract

Entities: Chemical Gene Species

Mesh：

Substances：

Year: 2019 PMID： 30427989 DOI： 10.1001/jamadermatol.2018.3906

Source DB: PubMed Journal: JAMA Dermatol ISSN： 2168-6068 Impact factor: 10.282

Keyword Cloud
Cited

× No keyword cloud information.

11 in total

Review 1. [Modern systemic therapies for atopic dermatitis : Which factors determine the choice of therapy?]

Authors: Stephan Traidl; Annice Heratizadeh
Journal: Dermatologie (Heidelb) Date: 2022-06-01

Review 2. Immunotargets and Therapy for Prurigo Nodularis.

Authors: Angelina Labib; Teresa Ju; Ashley Vander Does; Gil Yosipovitch
Journal: Immunotargets Ther Date: 2022-04-26

3. Chronic Nodular Prurigo: A European Cross-sectional Study of Patient Perspectives on Therapeutic Goals and Satisfaction.

Authors: Manuel P Pereira; Claudia Zeidler; Joanna Wallengren; Jon Anders Halvorsen; Elke Weisshaar; Simone Garcovich; Laurent Misery; Emilie Brenaut; Ekin Şavk; Nikolay Potekaev; Andrey Lvov; Svetlana Bobko; Jacek C Szepietowski; Adam Reich; Agnieszka Bozek; Franz J Legat; Martin Metz; Markus Streit; Esther Serra-Baldrich; Margarida Gonçalo; Michael Storck; Teresa Nau; Vincent Hoffmann; Sabine Steinke; Ina Greiwe; Martin Dugas; Matthias Augustin; Sonja Ständer
Journal: Acta Derm Venereol Date: 2021-02-17 Impact factor: 3.875

Reduced Itch Associated With Dupilumab Treatment In 4 Patients With Prurigo Nodularis.

Review 1. [Modern systemic therapies for atopic dermatitis : Which factors determine the choice of therapy?]

Review 2. Immunotargets and Therapy for Prurigo Nodularis.

3. Chronic Nodular Prurigo: A European Cross-sectional Study of Patient Perspectives on Therapeutic Goals and Satisfaction.

4. Resolution of Treatment-Refractory Prurigo Nodularis With Dupilumab: A Case Series.

5. Recalcitrant prurigo nodularis treated successfully with dupilumab.

6. Chronic Pruritus Responding to Dupilumab-A Case Series.

Review 7. Learning From Success and Failure: Biologics for Non-approved Skin Diseases.

Review 8. The Neuromodulatory Effect of Antipruritic Treatment of Chronic Prurigo.

Review 9. Emerging Therapeutic Options for Chronic Pruritus.

Review 10. A New Generation of Treatments for Itch.